// App-Quantinova.ai

T5073 2016 AHA : Drug-Eluting Stents in the Treatment of Saphenous Vein Graft Disease: Disappointing Outcome During Long-term Follow-up

Researchers

Presenter

  • David L Fischman

Principal Investigators

  • Philip Durney

  • Brandon M Madsen

  • Paul Walinsky

  • Michael Gannon

  • Babu Jasti

  • David Ogilby

  • Melissa McCarey

  • Suzanne Adams

  • Michael P Savage

Medical Centers

  • Thomas Jefferson University, Philadelphia, PA

  • Northwell Health, Manhasset, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Saphenous vein graft (SVG) disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Nicardipine Hydrochloride

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved